HBV Pre-S1-Derived Myristoylated Peptide (Myr47): Identification of the Inhibitory Activity on the Cellular Uptake of Lipid Nanoparticles

The Myr47 lipopeptide, consisting of hepatitis B virus (HBV) pre-S1 domain (myristoylated 2–48 peptide), is an effective commercialized anti-HBV drug that prevents the interaction of HBV with sodium taurocholate cotransporting polypeptide (NTCP) on human hepatocytes, an activity which requires both...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanahara, Masaya, Chang, Ya-Ting, Somiya, Masaharu, Kuroda, Shun’ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157113/
https://www.ncbi.nlm.nih.gov/pubmed/34067884
http://dx.doi.org/10.3390/v13050929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157113/
https://www.ncbi.nlm.nih.gov/pubmed/34067884
http://dx.doi.org/10.3390/v13050929

Ejemplares similares